25 May 2013
Keywords: nexstar, begin, ph, ii, mikasome, trials, pharmaceuticals
Article | 20 November 1997
- NeXstar Pharmaceuticals is to begin Phase II clinical trials ofMiKasome, its liposomal formulation of the antibiotic amikacin. The
trial will ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 September 1997
24 July 1997
24 May 2013
© 2013 thepharmaletter.com